SCHEMBL4572170

SCHEMBL4572170

CC1CCC(C2CCC3CC(O)CCC3C2)CC1

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.32
TRPM8 Q7Z2W7 2/20 0.32
LMNA P02545 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18272049 0.87 TRPA1 (0.38) TRPA1TRPM8LMNACYP2C9
SCHEMBL15725303 0.87 TRPA1 (0.38) TRPA1TRPM8LMNACYP2C9
SCHEMBL19288961 0.84 LMNA (0.35) TRPA1TRPM8LMNACYP2C9
SCHEMBL19771716 0.84 LMNA (0.35) TRPA1TRPM8LMNACYP2C9
SCHEMBL4569171 0.84 TSHR (0.37) LMNACYP2C9
SCHEMBL16248250 0.84 TSHR (0.37) TRPA1TRPM8
SCHEMBL14318801 0.84 TSHR (0.37) TRPA1TRPM8
SCHEMBL2612208 0.84 TSHR (0.37) TRPA1TRPM8
SCHEMBL6840454 0.84
SCHEMBL9909852 0.82 LMNA (0.33) LMNACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420854-B2 Di(meth)acrylate compound, polymerizable liquid crystal composition, optical anisotropic material, optical element and optical information writing/reading device ASAHI GLASS COMPANY, LIMITED (JP) 2013-04-16 US disclosed
US-20120123074-A1 DI(METH)ACRYLATE COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL, OPTICAL ELEMENT AND OPTICAL INFORMATION WRITING/READING DEVICE ASAHI GLASS COMPANY, LIMITED (JP) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120123074-A1 DI(METH)ACRYLATE COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL, OPTICAL ELEMENT AND OPTICAL INFORMATION WRITING/READING DEVICE METTL3, METTL14, METTL16 TRPA1 1460/4885TRPM8 4465/4885LMNA 2893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.